Literature DB >> 27214119

The impact of premature ejaculation on the subjective perception of orgasmic intensity: validation and standardisation of the 'Orgasmometer'.

E Limoncin1, F Lotti2, M Rossi2, E Maseroli2, G L Gravina1, G Ciocca1, D Mollaioli1, S Di Sante3, M Maggi2, A Lenzi4, E A Jannini3.   

Abstract

To the best of our knowledge, no psychometric tools have been specifically developed to measure if premature ejaculation (PE) is related to low sexual pleasure in terms of perception of orgasmic intensity. Hence, the aim of this study was to evaluate if men with PE suffer from a low perception of orgasmic intensity using a new tool, the 'Orgasmometer', to quantitatively measure the intensity of orgasmic pleasure. Among 329 subjects attending our andrological unit for suspected PE, 257 men fulfilled the inclusion criteria. Of these, 156 (60.7%; 156/257) were affected by PE (PE group) and 101 (39.3%; 101/257) did not have any sexual dysfunction (Control group). Men were requested to fill out the Premature Ejaculation Diagnostic Tool (PEDT) and the Orgasmometer, a new visual tool recording orgasm intensity on a Likert scale. Interestingly, MANCOVA analysis revealed a statistically significant difference between the two groups (p = 0.044) in the subjective perception of orgasm intensity with the PE group scoring lower on the Orgasmometer (mean 5.8; 95% CI 5.191-6.409) than the Control group (mean 7.95; 95% CI 7.033-8.87). In addition, multiple linear regression revealed an inverse correlation between the PEDT and the Orgasmometer scores (p < 0.0001). Hence, higher PEDT scores were associated with a lower subjective perception of orgasmic intensity. The Orgasmometer was well understood, had good test-retest reliability and a high AUC in differentiating between men with high and low orgasmic pleasure intensity. The ROC curve analysis showed that a cut-off ≤6 had 87.7% sensitivity (95% CI 79.6-92.6), 95% specificity (95% CI 88.7-98.4), 95.3% positive predictive value (PPV) and 86.4% negative predictive value (NPV). Men affected by premature ejaculation perceived significantly lower orgasmic intensity than sexually healthy men. The Orgasmometer is an easy-to-perform, user-friendly tool for measuring orgasmic intensity.
© 2016 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  Orgasmometer; low sexual desire; orgasmic intensity; premature ejaculation; psychometric tools

Mesh:

Year:  2016        PMID: 27214119     DOI: 10.1111/andr.12220

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  13 in total

Review 1.  Redefining a sexual medicine paradigm: subclinical premature ejaculation as a new taxonomic entity.

Authors:  Elena Colonnello; Giacomo Ciocca; Erika Limoncin; Andrea Sansone; Emmanuele A Jannini
Journal:  Nat Rev Urol       Date:  2021-01-13       Impact factor: 14.432

2.  Hypersexuality as a tip of the iceberg of a primary psychopathology: a joined position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) and of the Italian Society of Psychopathology (SOPSI).

Authors:  E Limoncin; G Ciocca; G Castellini; A Sansone; F Cavalieri; F Cavallo; T Cocchiaro; V Ricca; G di Lorenzo; A Rossi; A D Fisher; V Rochira; G Corona; E A Jannini
Journal:  J Endocrinol Invest       Date:  2022-05-09       Impact factor: 5.467

3.  Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS).

Authors:  A Sansone; A Aversa; G Corona; A D Fisher; A M Isidori; S La Vignera; E Limoncin; M Maggi; M Merico; E A Jannini
Journal:  J Endocrinol Invest       Date:  2020-10-30       Impact factor: 4.256

4.  Validity of premature ejaculation diagnostic tool and its association with International Index of Erectile Function-15 in Chinese men with evidence-based-defined premature ejaculation.

Authors:  Dong-Dong Tang; Chao Li; Dang-Wei Peng; Xian-Sheng Zhang
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

5.  Pelvic muscle floor rehabilitation as a therapeutic option in lifelong premature ejaculation: long-term outcomes.

Authors:  Antonio Luigi Pastore; Giovanni Palleschi; Andrea Fuschi; Yazan Al Salhi; Alessandro Zucchi; Giorgio Bozzini; Ester Illiano; Elisabetta Costantini; Antonio Carbone
Journal:  Asian J Androl       Date:  2018 Nov-Dec       Impact factor: 3.285

6.  Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F.

Authors:  Daniele Mollaioli; Stefania Di Sante; Erika Limoncin; Giacomo Ciocca; Giovanni Luca Gravina; Elisa Maseroli; Egidia Fanni; Linda Vignozzi; Mario Maggi; Andrea Lenzi; Emmanuele A Jannini
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

7.  Penile sensory thresholds in subtypes of premature ejaculation: implications of comorbid erectile dysfunction.

Authors:  Xiang Chen; Fei-Xiang Wang; Chao Hu; Nian-Qin Yang; Ji-Can Dai
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

8.  Evaluation of the Mistakes in Self-Diagnosis of Sexual Dysfunctions in 11,000 Male Outpatients: A Real-Life Study in An Andrology Clinic.

Authors:  Giovanni Burgio; Bruno Giammusso; Aldo E Calogero; Daniele Mollaioli; Rosita A Condorelli; Emmanuele A Jannini; Sandro La Vignera
Journal:  J Clin Med       Date:  2019-10-14       Impact factor: 4.241

9.  The Sentiment Analysis of Tweets as a New Tool to Measure Public Perception of Male Erectile and Ejaculatory Dysfunctions.

Authors:  Andrea Sansone; Angelo Cignarelli; Giacomo Ciocca; Carlotta Pozza; Francesco Giorgino; Francesco Romanelli; Emmanuele A Jannini
Journal:  Sex Med       Date:  2019-08-05       Impact factor: 2.491

Review 10.  Lifestyles and sexuality in men and women: the gender perspective in sexual medicine.

Authors:  Daniele Mollaioli; Giacomo Ciocca; Erika Limoncin; Stefania Di Sante; Giovanni Luca Gravina; Eleonora Carosa; Andrea Lenzi; Emmanuele Angelo Francesco Jannini
Journal:  Reprod Biol Endocrinol       Date:  2020-02-17       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.